Actively Recruiting
Establishment and Promotion of an AI-Based Early Warning System for Prostate and Bladder Cancer Screening in the Male Community Population of Beijing
Led by Peking University First Hospital · Updated on 2026-01-06
3000
Participants Needed
1
Research Sites
204 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Prostate cancer is one of the most common malignancies in the male genitourinary system, and it is also the cancer with the fastest-growing incidence and mortality rates among men in China. Although prostate cancer screening can significantly reduce mortality, China has not yet established a well-developed screening system, which is one of the reasons why its mortality rate remains notably higher than that of Western countries. The primary objective of this project is to establish an efficient screening-diagnosis-treatment pathway, beginning with screening in community hospitals, followed by definitive diagnosis in secondary hospitals, and finally treatment in tertiary hospitals. Additionally, the project aims to achieve multi-institutional and multi-terminal sharing of disease information as well as dynamic monitoring and follow-up. The feasibility and effectiveness of this model will be validated through statistical analysis of the data.
CONDITIONS
Official Title
Establishment and Promotion of an AI-Based Early Warning System for Prostate and Bladder Cancer Screening in the Male Community Population of Beijing
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male community residents aged 50 years or older
- Life expectancy greater than 10 years and ECOG performance status of 0-2
- Permanent residents of Beijing willing to cooperate with screening, complete tests and questionnaires, and participate in follow-up
- Support for the research project and provision of signed informed consent
You will not qualify if you...
- Presence of any other malignant tumor or pre-existing prostate malignancy
- Presence of prostatitis or active infection in other parts of the urinary system
- Inability to cooperate with study procedures or other factors making participation unsuitable
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Urology, Peking University First Hospital, Beijing, 100034
Beijing, China
Actively Recruiting
Research Team
Z
Zejin Ou
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here